<DOC>
	<DOCNO>NCT00979290</DOCNO>
	<brief_summary>The fixed-dose combination ( FDC ) two antituberculous drug one capsule tablet available prevent development drug resistance . However , fixed-dose combination regimen consistent dosage usually give . The present available FDC chemotherapy ( Rifater ) pulmonary tuberculosis use Taiwan high ratio isoniazid rifampin pyrazinamide . The high risk drug toxicity adverse reaction use fixed-dose combination regimen consider . The aim present study compare toxicity use FDC regimen ( Rifater/Rifinah ) Taiwan single drug treatment newly diagnose pulmonary tuberculosis . The investigator also evaluate efficacy two regimen determine incidence discontinuation TB drug predispose factor two regimen .</brief_summary>
	<brief_title>Adverse Reactions Efficacy Fixed-dose Combination Anti-tuberculosis ( TB ) Drugs</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<criteria>1 . Newly diagnose pulmonary TB extrapulmonary TB patient 2 . No previous antiTB drug treatment 3 . Ageâ‰¥18years old 1 . Expected life &lt; 6months 2 . Baseline AST/ALT &gt; 3x upper limit normal ( ULN ) 3 . Age &lt; 18years old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Fix-dose combination anti-TB drug</keyword>
	<keyword>adverse effect</keyword>
	<keyword>efficiency</keyword>
</DOC>